Cost-effectiveness of tissue plasminogen activator for acute ischemic stroke.
Cost-effectiveness of tissue plasminogen activator for acute ischemic stroke.
复制标题
组织纤溶酶原激活剂治疗急性缺血性中风的成本效益。
DOI：
10.1212/wnl.52.4.894-a
复制
发表时间：
1999
期刊：
影响因子：
9.9
通讯作者：
S. Fagan
中科院分区：
文献类型：
--
作者：
J. Riggs;Morgantown;Zurab Nadareishvili;Paul J. Oh;L. Smurawska;Chau T T Tran;J. Norris;S. Fagan
有效性和资源使用数据的相关日期摘自1991年1月至1994年10月进行的NINDS rt-PA卒中试验，其结果于1995年发表。从1982年至1997年期间发表的研究中获得与事件流行病学过程相关的临床概率。与不同排放状态有关的效用值是根据1994年和1995年发表的研究得出的。成本数据摘自1991年至1996年期间发表的研究报告。财政年度是1996年。
Dates to which data relate Effectiveness and resource use data were extracted from NINDS rt-PA Stroke Trial conducted between January 1991 and October 1994, the results of which were published in 1995. Clinical probabilities relating to the epidemiological course of events were obtained from studies published between 1982 and 1997. The utility values related to different discharge states were based on studies published in 1994 and 1995. The cost data were extracted from studies published between 1991 and 1996. The fiscal year was 1996.